<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">862423</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2022.862423</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin</article-title>
<alt-title alt-title-type="left-running-head">Menko et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Hyaluronic Acid Impacts Lens Fibrosis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Menko</surname>
<given-names>A. Sue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1346844/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romisher</surname>
<given-names>Alison</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Walker</surname>
<given-names>Janice L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1651410/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pathology</institution>, <institution>Anatomy and Cell Biology</institution>, <institution>Sidney Kimmel Medical College</institution>, <institution>Thomas Jefferson University</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Ophthalmology</institution>, <institution>Sidney Kimmel Medical College</institution>, <institution>Thomas Jefferson University</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country>United&#x20;States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/260339/overview">Zhichao Fan</ext-link>, UCONN Health, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/397865/overview">Sara Pedron</ext-link>, University of Illinois at Urbana-Champaign, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1465845/overview">Adam Midgley</ext-link>, Nankai University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Janice L. Walker, <email>janice.walker@jefferson.edu</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>862423</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Menko, Romisher and Walker.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Menko, Romisher and Walker</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Hyaluronic Acid/Hyaluronan (HA) is a major component of the provisional matrix deposited by cells post-wounding with roles both in regulating cell migration to repair a wound and in promoting a fibrotic outcome to wounding. Both are mediated through its receptors CD44 and RHAMM. We now showed that HA is present in the provisional matrix assembled on the substrate surface in a lens post-cataract surgery explant wound model in which mesenchymal leader cells populate the wound edges to direct migration of the lens epithelium across the adjacent culture substrate onto which this matrix is assembled. Inhibiting HA expression with 4-MU blocked assembly of FN-EDA and collagen I by the wound-responsive mesenchymal leader cells and their migration. These cells express both the HA receptors CD44 and RHAMM. CD44&#x20;co-localized with HA at their cell-cell interfaces. RHAMM was predominant in the lamellipodial protrusions extended by the mesenchymal cells at the leading edge, and along HA fibrils organized on the substrate surface. Within a few days post-lens wounding the leader cells are induced to transition to &#x3b1;SMA&#x2b; myofibroblasts. Since HA/RHAMM is implicated in both cell migration and inducing fibrosis we examined the impact of blocking HA synthesis on myofibroblast emergence and discovered that it was dependent on HA. While RHAMM has not been previously linked to the intermediate filament protein vimentin, our studies with these explant cultures have shown that vimentin in the cells&#x2019; lamellipodial protrusions regulate their transition to myofibroblast. PLA studies now revealed that RHAMM was complexed with both HA and vimentin in the lamellipodial protrusions of leader cells, implicating this HA/RHAMM/vimentin complex in the regulation of leader cell function post-wounding, both in promoting cell migration and in the transition of these cells to myofibroblasts. These results increase our understanding of how the post-wounding matrix environment interacts with receptor/cytoskeletal complexes to determine whether injury outcomes are regenerative or fibrotic.</p>
</abstract>
<kwd-group>
<kwd>lens</kwd>
<kwd>wound-repair</kwd>
<kwd>provisional matrix</kwd>
<kwd>hyaluronic acid</kwd>
<kwd>CD44</kwd>
<kwd>RHAMM</kwd>
<kwd>fibrosis</kwd>
</kwd-group>
<contract-num rid="cn001">EY021784</contract-num>
<contract-sponsor id="cn001">National Eye Institute<named-content content-type="fundref-id">10.13039/100000053</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>A tissue&#x2019;s extracellular matrix (ECM) microenvironment has significant effects on cell behavior, as first revealed in studies from Mina Bissell&#x2019;s lab (<xref ref-type="bibr" rid="B13">Bissell 2016</xref>). Their data showed that there is a dynamic reciprocity between cells and their surrounding ECM that impacts their biomechanical properties (<xref ref-type="bibr" rid="B91">Roskelley and Bissell 1995</xref>; <xref ref-type="bibr" rid="B82">Nelson and Bissell 2005</xref>; <xref ref-type="bibr" rid="B83">Nelson and Bissell 2006</xref>). This leads to changes in gene expression that can alter cell function to drive disease processes. More recently, it has become clear that, in response to wounding, both the composition and physical properties of the matrix produced to promote tissue repair/regeneration can become pro-fibrotic, as well as contribute to cancer progression (<xref ref-type="bibr" rid="B65">Lu et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B51">Kim et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B11">Basta et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B22">Correa-Gallegos and Rinkevich 2021</xref>; <xref ref-type="bibr" rid="B109">Tolg et&#x20;al., 2021</xref>). These pro-fibrotic, post-wounding matrix microenvironments promote fibrosis in part by inducing cells that regulate wound-repair to acquire and maintain a myofibroblast phenotype (<xref ref-type="bibr" rid="B40">Hinz 2016</xref>; <xref ref-type="bibr" rid="B49">Karppinen et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B102">Tai et&#x20;al., 2021</xref>).</p>
<p>Wound-induced provisional matrix proteins like fibronectin and collagen I are among the components of the wound-healing microenvironment that have been linked to promoting fibrosis. We show that specific expression of these matrix proteins by mesenchymal leader cells that populate the wound edge in response to cataract surgery wounding and their transition to myofibroblasts is dependent on TGF&#x3b2; (<xref ref-type="bibr" rid="B11">Basta et&#x20;al., 2021</xref>). These studies were performed with an <italic>ex vivo</italic> post-cataract surgery explant model that mimics both lens epithelial wound repair and the pathological fibrotic outcome of Posterior Capsule Opacification (PCO) (<xref ref-type="bibr" rid="B113">Walker et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B114">Walker et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). These wounded lens explant cultures provide an ideal reductionist model for investigating how provisional matrices organized to promote cell migration in response to wounding can lead to fibrotic disease progression. They are created by performing a mock cataract surgery on chick embryo lenses, <italic>ex vivo</italic>. This microsurgery removes the lens fiber cell mass and leaves behind the lens epithelial cell monolayer closely linked to the basement membrane capsule that surrounds the lens. Interdigitated among the lens epithelial cells are a subpopulation of mesenchymal cells that we have identified as resident immune cells. Resident immune cells are among the earliest responders to a wound site (<xref ref-type="bibr" rid="B85">Oishi and Manabe 2018</xref>), with a primary function of maintaining tissue homeostasis (<xref ref-type="bibr" rid="B57">Lech et&#x20;al., 2012</xref>), earning them the moniker of the &#x201c;sentinels of the immune system&#x201d; (<xref ref-type="bibr" rid="B25">Davies et&#x20;al., 2013</xref>). Our studies demonstrate that resident immune cells are immediate responders to lens wounding, rapidly populating the wound edges in both the chick lens mock cataract surgery explants and in human pediatric post-cataract surgery explants (<xref ref-type="bibr" rid="B76">Menko et&#x20;al., 2021</xref>). These vimentin-rich mesenchymal leader cells express CD45, CD44 and MHCII (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B76">Menko et&#x20;al., 2021</xref>), and display properties of professional phagocytes (<xref ref-type="bibr" rid="B112">Walker and Menko 2021</xref>), features they share with resident immune cells in other tissues (<xref ref-type="bibr" rid="B5">Arandjelovic and Ravichandran 2015</xref>; <xref ref-type="bibr" rid="B63">Lim et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B85">Oishi and Manabe 2018</xref>). Their presence in the lens and their response to lens injury involve important roles in directing lens wound repair (<xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B14">Bleaken et&#x20;al., 2016</xref>). Like other tissue resident immune cells, the resident immune cells would also induce activation of an adaptive immune response, as occurs in response to lens injury (<xref ref-type="bibr" rid="B46">Jiang et&#x20;al., 2018</xref>) and dysgenesis (<xref ref-type="bibr" rid="B64">Logan et&#x20;al., 2017</xref>).</p>
<p>While the primary function of tissue resident immune cells is to maintain homeostasis, they can become agents of pathogenesis (<xref ref-type="bibr" rid="B15">Boyman et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B25">Davies et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B87">Richmond and Harris 2014</xref>; <xref ref-type="bibr" rid="B34">Ginhoux and Guilliams 2016</xref>; <xref ref-type="bibr" rid="B66">Lu et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B67">Masopust and Soerens 2019</xref>; <xref ref-type="bibr" rid="B6">Ardain et&#x20;al., 2020</xref>). In studies with human post-cataract surgery explants we show that the CD45&#x20;<sup>&#x2b;</sup> resident immune cells but not the lens epithelial cells in these explants, acquire a myofibroblast phenotype (<xref ref-type="bibr" rid="B76">Menko et&#x20;al., 2021</xref>). Cell tracking studies using antibody to CD44 that binds exclusively to the resident immune cells identified that the resident immune cells in the chick mock cataract surgery explant cultures were the progenitors of the &#x3b1;SMA&#x2b; myofibroblasts that appear in the mock cataract surgery explant cultures (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). The transition to &#x3b1;SMA&#x2b; myofibroblasts is a hallmark of PCO, a common fibrotic pathological outcome of cataract surgery, which also is characterized by cell proliferation, migration, and deposition of matrix proteins (<xref ref-type="bibr" rid="B121">Wormstone et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B120">Wormstone and Eldred 2016</xref>; <xref ref-type="bibr" rid="B75">Menko et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B112">Walker and Menko 2021</xref>; <xref ref-type="bibr" rid="B122">Wormstone et&#x20;al., 2021</xref>). While the matrix proteins in the wound microenvironment are key to signaling the acquisition of a fibrotic phenotype, we have also identified a requisite role for the intermediate filament protein vimentin associated with the mesenchymal leader cell population. These functions include directing the collective migration of lens epithelial cells (<xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>), and the transition of these leader cells to a myofibroblast phenotype (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>).</p>
<p>We now examine the impact of hyaluronic acid/hyaluronan (HA) and its receptors CD44 and Receptor for Hyaluronan Mediated Motility (RHAMM) post-wounding in studies with our clinically relevant, <italic>ex vivo</italic> mock cataract surgery wound repair/fibrosis model. HA is a glycosaminoglycan ubiquitously expressed in the ECM that also has been localized to the cytoplasm and the nucleus (<xref ref-type="bibr" rid="B89">Ripellino et&#x20;al., 1988</xref>; <xref ref-type="bibr" rid="B30">Evanko and Wight 1999</xref>; <xref ref-type="bibr" rid="B27">Dicker et&#x20;al., 2014</xref>). In the eye, HA is the principal component of the vitreous humor (<xref ref-type="bibr" rid="B16">Bremer and Rasquin 1998</xref>; <xref ref-type="bibr" rid="B99">Slevin et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B105">Theocharis et&#x20;al., 2008</xref>), from where it was first purified. HA is found from early stages of development in the basement membranes of many eye tissues, including the lens (<xref ref-type="bibr" rid="B86">Peterson et&#x20;al., 1995</xref>), and the interphotoreceptor matrix of the retina (<xref ref-type="bibr" rid="B43">Inatani and Tanihara 2002</xref>; <xref ref-type="bibr" rid="B103">Tanihara et&#x20;al., 2002</xref>). A salient feature of HA is its expression in the provisional matrix that is assembled in response to tissue wounding. HA functions in promoting cell migration, a central element in modulating tissue repair and regeneration (<xref ref-type="bibr" rid="B69">Maytin 2016</xref>). Important to our investigations, the presence of HA in the post-wounding microenvironment is also linked to the development of fibrosis (<xref ref-type="bibr" rid="B2">Albeiroti et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B69">Maytin 2016</xref>; <xref ref-type="bibr" rid="B102">Tai et&#x20;al., 2021</xref>). This property could, in part, reflect the reported role for HA in fibronectin fibrillogenesis (<xref ref-type="bibr" rid="B8">Assun&#xe7;&#xe3;o et&#x20;al., 2021</xref>). HA associates either directly or indirectly with many different proteins in the ECM. The relationship between HA and the accumulation of fibronectin in the matrix environment is highlighted in studies of the trabecular meshwork that showed blocking HA synthesis reduced the presence of fibronectin (<xref ref-type="bibr" rid="B50">Keller et&#x20;al., 2012</xref>). The complex, and sometimes antithetical, roles of HA in biological processes, pro-inflammatory and anti-inflammatory, promoting wound-repair/regeneration and promoting fibrosis, is determined by many different factors. These features include its size, modifications, structural organization, and binding to different receptors (<xref ref-type="bibr" rid="B3">Amorim et&#x20;al., 2021</xref>).</p>
<p>HA synthesis and turnover are tightly regulated (<xref ref-type="bibr" rid="B45">Jiang et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B9">Aya and Stern 2014</xref>; <xref ref-type="bibr" rid="B33">Garantziotis and Savani 2019</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>). Hyaluronan synthases (HASs), are the transmembrane enzymes responsible for producing HA, while hyaluronidases are the enzymes critical to breakdown of HA (<xref ref-type="bibr" rid="B45">Jiang et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B9">Aya and Stern 2014</xref>; <xref ref-type="bibr" rid="B33">Garantziotis and Savani 2019</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>). There are three HASs; HAS1, HAS2 and HAS3, which can exhibit distinct subcellular locations, expression patterns and regulation (<xref ref-type="bibr" rid="B44">Itano and Kimata 2002</xref>; <xref ref-type="bibr" rid="B38">Heldin et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>). Typically, HASs are localized at the plasma membrane where HA is secreted to the extracellular environment (<xref ref-type="bibr" rid="B44">Itano and Kimata 2002</xref>; <xref ref-type="bibr" rid="B38">Heldin et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>).</p>
<p>High molecular weight (HMW) HA accumulates at sites of injury and plays roles in promoting tissue remodeling and wound repair (<xref ref-type="bibr" rid="B45">Jiang et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B9">Aya and Stern 2014</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>). In the wound environment, hyaluronidases and free radicals can fragment HMW-HA into low molecular weight forms (LMW-HA) that are associated with promoting inflammation and disease (<xref ref-type="bibr" rid="B45">Jiang et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B9">Aya and Stern 2014</xref>; <xref ref-type="bibr" rid="B52">Kobayashi et&#x20;al., 2020</xref>). Many studies support a role for HA in the development of fibrosis in tissues such as the liver (<xref ref-type="bibr" rid="B4">Andreichenko et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B124">Yang et&#x20;al., 2019</xref>) and lung (<xref ref-type="bibr" rid="B61">Li et&#x20;al., 2011</xref>). HA was found to mediate fibroblast transition to a scar-inducing myofibroblast phenotype associated with fibrosis (<xref ref-type="bibr" rid="B77">Meran et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B118">Webber et&#x20;al., 2009</xref>). TGF&#x3b2;-induced differentiation of dermal fibroblasts to a myofibroblast phenotype is linked to HA production and assembly into a pericellular coat (<xref ref-type="bibr" rid="B77">Meran et&#x20;al., 2007</xref>). Interestingly, in this same study, nonscarring oral fibroblasts, were found resistant to TGF&#x3b2;-induced myofibroblast differentiation. This alternative response was associated with a lack of HA production and HA pericellular coat formation (<xref ref-type="bibr" rid="B77">Meran et&#x20;al., 2007</xref>). HA synthesis is also required for TGF&#x3b2;-induced differentiation of lung fibroblasts to myofibroblasts (<xref ref-type="bibr" rid="B118">Webber et&#x20;al., 2009</xref>). Surprisingly, providing lung fibroblasts with exogenous HA blocked myofibroblast differentiation, which was associated with the relocation of the HA receptor CD44 and TGF&#x3b2;R ALK5 from lipid raft to non-lipid raft regions of the membrane (<xref ref-type="bibr" rid="B118">Webber et&#x20;al., 2009</xref>). This paradoxical HA response lends support to the concept that HA presentation and organization are critical to how HA modulates cellular function (<xref ref-type="bibr" rid="B118">Webber et&#x20;al., 2009</xref>). These studies emphasize a key role for cell-associated HA in inducing a fibrotic response, and demonstrate that HA interactions with receptors at the membrane is essential to its functional outcomes.</p>
<p>Principal among the many receptors for HA, are CD44 and RHAMM; others include LYVE-1, TLR2 and TLR4 (<xref ref-type="bibr" rid="B33">Garantziotis and Savani 2019</xref>; <xref ref-type="bibr" rid="B1">Abatangelo et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B3">Amorim et&#x20;al., 2021</xref>). The interaction between HA and these receptors provide HA with the ability to activate many different downstream signaling effectors and impact cell behavior. Its cell-surface receptor CD44 is a single pass transmembrane glycoprotein expressed by a number of cell types including bone marrow mesenchymal cells, immune cells, embryonic stem cells and cancer stem cells (<xref ref-type="bibr" rid="B60">Levesque and Haynes 1996</xref>; <xref ref-type="bibr" rid="B19">Chen et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B58">Lee-Sayer et&#x20;al., 2018</xref>). CD44 has many functions including the regulation of cell migration and cell proliferation (<xref ref-type="bibr" rid="B54">Krolikoski et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B20">Chen et&#x20;al., 2020</xref>). The HA receptor RHAMM is even more complex. It is a multifunctional protein that localizes to both extracellular and intracellular sites. RHAMM has important roles both during development and in the wound-repair response that include mediating cell migration, from which it derives its name (<xref ref-type="bibr" rid="B94">Savani et&#x20;al., 1995</xref>; <xref ref-type="bibr" rid="B59">Leng et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B108">Tolg et&#x20;al., 2020</xref>). RHAMM localizes to the cell surface where it mediates binding to HA in the extracellular matrix environment, and to the cell nucleus where it associates with transcriptional complexes to regulate gene expression (<xref ref-type="bibr" rid="B72">Meier et&#x20;al., 2014</xref>). Studies also show localization of RHAMM to the cytoplasm and its association with both microtubules and actin filaments (<xref ref-type="bibr" rid="B7">Assmann et&#x20;al., 1999</xref>), as well as to the centrosome where it functions in regulating spindle pole stability (<xref ref-type="bibr" rid="B68">Maxwell et&#x20;al., 2003</xref>). Following wounding, RHAMM has been specifically localized to mesenchymal cells with a fibroblastic morphology that localize to the leading edge of the wound in response to injury (<xref ref-type="bibr" rid="B36">Hardwick et&#x20;al., 1992</xref>; <xref ref-type="bibr" rid="B94">Savani et&#x20;al., 1995</xref>). Like their ligand HA, both CD44 and RHAMM have been linked to the development of fibrosis (<xref ref-type="bibr" rid="B107">Tolg et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B23">Cui et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B35">Govindaraju et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B123">Wu et&#x20;al., 2021</xref>). In this study, we show that HA is expressed in the matrix microenvironment of the mesenchymal cells that are recruited to the leading edge of the wound where it is associated with both CD44 and RHAMM and induces cell migration and the transition of the mesenchymal leader cells to &#x3b1;SMA&#x2b; myofibroblasts.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>
<italic>Ex vivo</italic> Post-cataract Surgery Chick Explant Cultures and Inhibitor Treatment</title>
<p>
<italic>Ex vivo</italic> post-cataract surgery chicken explants were created as previously described (<xref ref-type="bibr" rid="B113">Walker et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B114">Walker et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). Briefly, lenses are removed from E15 chick embryos prior to performing mock cataract surgery to remove the lens fibers cells, leaving behind the wounded epithelial cells, a population that is tightly adherent to the lens capsule basement membrane. Cuts are made in the epithelium to create a star shaped explant that is flattened on the culture substrate. Eggs are procured from Poultry Futures (Lititz, PA). Experiments using chick embryo lenses comply with ARVO guidelines for animals. All animal studies are approved by the Institutional Animal Care and Use Committee (IACUC) at Thomas Jefferson University (Philadelphia, PA). For studies blocking HA synthesis, <italic>ex vivo</italic> post-cataract surgery explants were treated from day (D)1 through D3 in culture with the HA inhibitor 4-Methylumbelliferone (4-MU) at 400&#xa0;&#xb5;M (Selleckchem, Houston, Texas (IC50: .4&#xa0;mM)) or its vehicle (DMSO). Both vehicle and 4-MU were replaced each day and at D3&#x20;post-injury, cultures were fixed in 4% formaldehyde. The dose for 4-MU was chosen based both on the IC50 and the literature (<xref ref-type="bibr" rid="B88">Rilla et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B111">Vigetti et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B92">Saito et&#x20;al., 2013</xref>). Phase contrast images were acquired with a Nikon Eclipse T<italic>i</italic> microscope using NIS elements software. For migration studies, time-lapse imaging was set up D1&#x20;post-injury for 24&#xa0;h using a Tokai Hit stage-top incubator on a Nikon Eclipse TE2000-U microscope.</p>
</sec>
<sec id="s2-2">
<title>Immunofluorescence and Live Immunolabeling</title>
<p>For standard immunofluorescence studies, <italic>ex vivo</italic> post-cataract surgery explant cultures were fixed in 4% formaldehyde for 15&#xa0;min, permeabilized in 0.25% Triton-X-100 for 5&#xa0;min and blocked in 5% goat serum for 30&#xa0;min. Subsequently, explant cultures were incubated with primary antibodies for 30&#xa0;min to 1&#xa0;h followed by incubation with fluorescent-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA). For immunolabeling we used the following primary antibodies &#x3b1;SMA (Sigma Aldrich, St. Louis, MO or Abcam, Cambridge, MA), <italic>&#x3b1;</italic>-tubulin (Cell Signaling Technology, Danvers, MA), Collagen I alpha (Novus Biologicals, Centennial, CO), Fibronectin EDA (Santa Cruz Biotechnology, Santa Cruz, CA), HA (Abcam, Cambridge, MA) and RHAMM (Novus Biologicals, Centennial CO). The following primary antibodies were obtained from Developmental Studies Hybridoma Bank, created by the NICHD of the NIH (The University of Iowa, Department of Biology, Iowa City, IA): 1D10 monoclonal antibody to CD44 developed by Halfter, W.M. and AMF17B monoclonal antibody to vimentin deposited by Fulton, A.B. Explant cultures were counterstained with DAPI (Biolegend, San Diego, CA) to identify nuclei or fluorescent-conjugated Phalloidin (Invitrogen, Waltham, MA) to identify F-actin. For live antibody immunolabeling studies, cultures were incubated on the indicated day post-injury with HA (Abcam, Cambridge, MA), RHAMM (Novus Biologicals, Centennial CO), and/or CD44 antibody or with matched isotype controls (Jackson ImmunoResearch, West Grove, PA) for 20&#xa0;min on ice, fixed in 4% formaldehyde and processed for immunostaining with fluorescent-conjugated secondary antibodies (Jackson Immunoresearch, West Grove,&#x20;PA).</p>
</sec>
<sec id="s2-3">
<title>Proximal Ligation Assay</title>
<p>Proximal ligation assay was performed according to manufacturer&#x2019;s directions (Sigma Aldrich, St. Louis, MO) using antibodies to RHAMM and vimentin or RHAMM and&#x20;HA.</p>
</sec>
<sec id="s2-4">
<title>Confocal Microscopy Imaging</title>
<p>Images were captured using either a confocal Zeiss 510 or a confocal Zeiss 800 microscope. Z-stacks were collected with each optical plane at either 0.33&#xa0;&#xb5;m or 0.49&#xa0;&#xb5;m, as indicated. Images are shown as either single optical planes from the z-stack or as projected images.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Emergence of Fibrotic Disease in an Ex&#x20;Vivo Mock Cataract Surgery Explant Model</title>
<p>To create a model that mimics conditions associated with the emergence of fibrosis post-cataract surgery we performed microsurgery <italic>ex vivo</italic> on isolated E15 chick embryo lenses. The procedure involves removing the differentiated fiber cells that comprise the mass of lens tissue, as in human cataract surgery (<xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B115">Walker et&#x20;al., 2015</xref>). Following this, the lens epithelium, together with its subpopulation of mesenchymal resident immune cells, remain as an intact sheet closely linked to the thick basement membrane capsule surrounding the lens. The cataract-surgery wound edge is located where the fiber cells had bordered the lens epithelium. Secondary wound sites are created at cuts made in the anterior aspects of the lens capsular bag to flatten the wounded tissue explant on the tissue culture platform. From these cut sites, the wounded lens cell populations move off their basement membrane capsule onto and across the surrounding tissue culture platform (<xref ref-type="fig" rid="F1">Figures 1A,B</xref> (blue)). This region is referred to as the ExtraCapsular Zone (ECZ). As the wounded lens epithelial cells migrate across the ECZ they are directed by the wound-activated mesenchymal cell subpopulation, which rapidly populates the leading edge (<xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>). This mesenchymal leader cell population expands as the cells migrate across the substrate (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>). On the substrate surface, the mesenchymal leader cells assemble a complex provisional matrix that, we have shown previously, includes the EDA isoform of fibronectin (FN-EDA) (<xref ref-type="fig" rid="F1">Figures 1E,G</xref>). By D3&#x20;post-injury the mesenchymal leader cells express &#x3b1;SMA, a hallmark of their acquisition of a myofibroblast phenotype (<xref ref-type="fig" rid="F1">Figure&#x20;1F</xref>). This myofibroblast population expands significantly by culture D6 (<xref ref-type="fig" rid="F1">Figure&#x20;1H</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<italic>Ex vivo</italic> post-cataract surgery wound repair/fibrosis explant cultures. <bold>(A,B)</bold> Models created using a phase microscopy image of the star shaped <italic>ex vivo</italic> mock cataract surgery explant in culture at <bold>(A)</bold> culture D3 and <bold>(B)</bold> culture D6, on which is superimposed diagrams showing the movement of wound-activated lens epithelial cells across the adjacent culture substrate, referred to as the ExtraCapsular Zone (ECZ), shown in blue. The explant cultures also harbor a population of endogenous mesenchymal cells that rapidly migrate to the wound edges, direct the migration of the epithelium, acquire an &#x3b1;SMA&#x2b; myofibroblast phenotype at D3&#x20;post-wounding <bold>(F)</bold>, which expands greatly by D6&#x20;<bold>(H)</bold>, modeled in A,B in green. Phase contrast microscopy images showing the wounded lens epithelial cells and mesenchymal cells at the leading edge (white dashed line) at <bold>(C)</bold> D3 and <bold>(D)</bold> D6&#x20;post-wounding. The outside cut edge of the explant is indicated by a white dotted line. Along the substrate surface of the ECZ, the mesenchymal cells at the leading edge assemble a provisional matrix by D3&#x20;<bold>(E)</bold>, which expands by D6&#x20;<bold>(G)</bold>, which includes the ECM protein FN-EDA <bold>(E,G)</bold>. Images are presented as a projection from the collected confocal z-stack with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bar &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Hyaluronic Acid Is an Integral Component of the Provisional Matrix Organized Post-lens Wounding</title>
<p>While the literature shows that hyaluronic acid (HA) is expressed in response to wounding, where it is an integral component of the provisional matrix organized to promote wound-healing, its presence in the wound microenvironment has also been linked to fibrosis (<xref ref-type="bibr" rid="B2">Albeiroti et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B69">Maytin 2016</xref>; <xref ref-type="bibr" rid="B102">Tai et&#x20;al., 2021</xref>). We examined whether HA is a component of the provisional matrix organized on the substrate surface of the ECZ by the mesenchymal leader cells activated by mock cataract surgery wounding. For these studies, explant cultures were live-immunolabeled at 7&#xa0;days post-wounding with an antibody to HA, fixed, tagged with a fluorescent-secondary antibody and imaged by confocal microscopy. The results showed that an extensive fibrillar HA network forms on the substrate surface as a component of the provisional matrix organized by the wound-activated cells migrating across the ECZ (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>HA is a key element of the provisional matrix microenvironment post-wounding. <bold>(A)</bold> Post-cataract surgery explant model with a white box representative of the region examined in this study. <bold>(B,C)</bold> Live-immunolabeling of HA (green) of lens post-mock surgery explant cultures shown at D7 following imaging by confocal microscopy using the tiling feature to image across a large area of the ECZ. Dotted line indicates the border of the lens capsule explant and the ECZ. Boxed region in B is shown at higher magnification in C revealing that HA is synthesized and organized as a component of the provisional matrix formed in response to wounding. Magnification bar &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Fibronectin-EDA Matrix Organized Along Hyaluronic Acid Fibrils Formed in Response to Lens Wounding</title>
<p>As we have shown previously (<xref ref-type="bibr" rid="B11">Basta et&#x20;al., 2021</xref>), a FN-EDA provisional matrix is organized at the leading edge of the wound-activated cells migrating across the substrate surface adjacent to the injured lens explant (<xref ref-type="fig" rid="F1">Figures 1E,G</xref>). We now investigated whether the HA provisional matrix produced by these cells in response to mock cataract surgery wounding provides a substrate on which FN-EDA fibrils or organized. Mock cataract surgery explant cultures were live labeled for HA at both 3- and 6-days post-wounding. Following fixation and tagging with secondary antibody, the cultures were co-immunolabeled with an FN-EDA antibody, and imaged by confocal microscopy (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>). These studies revealed that the FN-EDA matrix assembled on the substrate at the leading edge of the ECZ during the first 3&#x20;days post-wounding is organized along the fibrils of the provisional HA matrix produced by the wound-activated mesenchymal leader cells (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>). The coincidence of the HA and FN-EDA matrices on the substrate surface beneath the mesenchymal cell population at the leading edge of the extracapsular zone remains a defining feature of the explant cultures at culture day 6 (<xref ref-type="fig" rid="F3">Figures 3D&#x2013;F</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>FN-EDA assembled along HA fibrils in the matrix formed post-wounding. <bold>(A&#x2013;F)</bold> <italic>Ex vivo</italic> lens post-wounding explant cultures at <bold>(A&#x2013;C)</bold> D3 and <bold>(D&#x2013;F)</bold> D6 were live immunolabeled for HA <bold>(A,D)</bold>, fixed and immunolabeled for FN-EDA <bold>(B,E)</bold> and imaged at the leading edge of the ECZ (indicated by white arrow) by confocal microscopy. <bold>(C,F)</bold> Colocalization of HA and FN-EDA shown together with DAPI labeling of nuclei. Box with white dotted line in F is shown as an inset at higher magnificent and intensity adjusted. These studies show that FN-EDA is organized along HA fibrils. Images are presented as a projection from the collected confocal z-stack with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bar &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Hyaluronic Acid Receptors CD44 and Receptor for Hyaluronan Mediated Motility Expressed by Leading Edge Cells Post-lens Wounding</title>
<p>The most prominent among the HA receptors are CD44 and RHAMM. They are molecularly distinct receptors. CD44 is a transmembrane glycoprotein typically expressed by immune cells, bone marrow mesenchymal cells, embryonic stem cells, and cancer stem cells (<xref ref-type="bibr" rid="B19">Chen et&#x20;al., 2018</xref>). RHAMM is commonly expressed by the migrating cells at a wound edge with multiple subcellular regions of localization including the cell surface, the cytoplasm, and the nucleus (<xref ref-type="bibr" rid="B36">Hardwick et&#x20;al., 1992</xref>; <xref ref-type="bibr" rid="B94">Savani et&#x20;al., 1995</xref>). In previous studies, we had identified that CD44 was expressed by the mesenchymal cells that populate that wound edge in response to mock cataract surgery (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B11">Basta et&#x20;al., 2021</xref>). We now have performed a co-localization analyses to determine the relative patterns of expression of CD44 and RHAMM by the mesenchymal cells at the leading edge of the ECZ during the first few days following mock cataract surgery wounding. For these studies, the wounded lens explant cultures were fixed and permeabilized at culture D2 and D3, prior to immunolabeling for CD44 and RHAMM. The results showed that both these HA receptors were expressed by the cells that populate the leading-edge post-mock cataract surgery wounding, each with a distinct pattern of expression (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>). At D2&#x20;post-wounding, CD44 was most highly expressed along their cell borders and was also localized to the tips of the lamellipodial processes they extend along the substrate at the leading edge (<xref ref-type="fig" rid="F4">Figures 4A,C</xref>). While labeling intensity was diminished, this pattern of CD44 localization was retained at culture day 3 when these cells first acquire a myofibroblast phenotype (<xref ref-type="fig" rid="F4">Figures 4D,F</xref>). In contrast to CD44, RHAMM was primarily localized to the lamellipodial processes extended by the mesenchymal cells at the leading edge of the ECZ at culture day 2 (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). Here, there is some co-localization of RHAMM with CD44 at the cells&#x2019; lamellipodial tips (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). This pattern of RHAMM localization is retained by the cells at the leading edge at D3&#x20;post-wounding, after these cells have acquired a myofibroblast phenotype (<xref ref-type="fig" rid="F4">Figures&#x20;4E,F</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The HA receptors CD44 and RHAMM are expressed by mesenchymal leader cells responding to lens wounding. <italic>Ex vivo</italic> lens post-wounding explant cultures at <bold>(A&#x2013;C)</bold> D2 and <bold>(D&#x2013;F)</bold> D3&#x20;co-immunolabeled for <bold>(A,D)</bold> CD44 and <bold>(B,E)</bold> RHAMM, imaged by confocal microscopy at the leading edge of the ECZ, and <bold>(C,F)</bold> shown as merged images together with DAPI labeling of nuclei. CD44 and RHAMM have distinct patterns of localization, with CD44 most prominent at the edges of the mesenchymal cells along their cell-cell borders and RHAMM predominately localized to the lamellipodial processes extended along the substrate at the leading edge, co-localizing with CD44 at the tips of these lamellipodia. Images are presented as single optical section from a confocal z-stack with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bars &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>CD44 Colocalizes With Hyaluronic Acid at Cell-Cell Interfaces of Leader Cells Post-wounding</title>
<p>Following their transition to myofibroblasts, these cells expand to comprise a large area at the leading edge of the ECZ (<xref ref-type="fig" rid="F1">Figures 1D,H</xref>). The coincidence of HA with its receptor CD44 was investigated in these cells by live labeling the mock cataract surgery explant cultures at 7&#xa0;days post-wounding for both HA and CD44. High-resolution confocal microscopy imaging was performed at the leading edge of the ECZ (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). This approach revealed two distinct patterns of HA organization in the matrix microenvironment, one aligned with cell-cell borders (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>, arrow, from boxed in region of <xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>), the other organized in fibrous cords (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>, arrowhead). CD44 was colocalized with HA at cells&#x2019; lamellipodia edges concentrated along their cell-cell borders (<xref ref-type="fig" rid="F5">Figure&#x20;5B,Bi,C,Ci</xref>). No labeling for CD44 was observed along the network of HA extracellular matrix fibrils (<xref ref-type="fig" rid="F5">Figures 5A,C</xref>, arrowhead).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>CD44 colocalized with HA in the region of cell-cell interfaces of mesenchymal leader cells. <italic>Ex vivo</italic> post-cataract surgery explant cultures were live immunolabeled at D7 for both HA <bold>(A,Ai)</bold> and CD44&#x20;<bold>(B,Bi)</bold>, imaged by confocal microscopy at the leading edge of the ECZ and <bold>(C,Ci)</bold> shown as merged images together with DAPI labeling of nuclei. Boxed areas in A-C are shown at higher magnification in Ai-Ci. CD44 colocalizes with HA along cell-cell interfaces (white arrow). No labeling for CD44 was detected along HA fibrils (arrowhead). Images are presented as a projection from a collected confocal z-stack with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bars &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Receptor for Hyaluronan Mediated Motility Colocalizes With Hyaluronic Acid Fibrillar Network Post-wounding</title>
<p>The HA receptor RHAMM, which functions in cell migration, has roles as both a cell surface and an intracellular molecule. To provide insight into the different RHAMM localizations in the migrating cells at the leading edge of the ECZ, explant cultures at 6&#xa0;days post-wounding wounding were either fixed and immunolabeled for RHAMM (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>) or live labeled with the RHAMM antibody (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). Confocal microscopy imaging at the leading edge revealed the presence of both intracellular (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>) and cell surface-associated (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>) populations of RHAMM at D6&#x20;post-wounding. In the fixed explant cultures, RHAMM localized to the tips of the lamellipodia that the cells extended along the cell surface (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>, arrow). This pattern of localization was consistent with that observed for RHAMM in leading edge cells at culture D2 and D3 (<xref ref-type="fig" rid="F4">Figures 4B,E</xref>). At D6, RHAMM also localized along actin stress fiber-like cytoskeletal structures in this mesenchymal leader cell population (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>, arrowhead). Live labeling revealed that cell-surface linked RHAMM was present at the tips of the protrusions the cells extend at the leading edge (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>, arrow) and in a filamentous distribution in the cells just behind the migrating edge with a distribution similar to that of the fibrous network of HA (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>, arrowhead). To examine the co-incidence of this cell surface RHAMM population with the HA extracellular fibrils <italic>ex vivo</italic> post-cataract surgery explants were live labelled with antibodies to both RHAMM and HA. Confocal imaging at the leading edge of the ECZ confirmed the colocalization of cell-surface RHAMM with HA fibrils (<xref ref-type="fig" rid="F6">Figures 6C&#x2013;E</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>RHAMM localizes along HA fibrils. To distinguish intracellular and extracellular RHAMM populations, <italic>ex vivo</italic> post-cataract surgery explant cultures at D6 were either <bold>(A)</bold> fixed, permeabilized, and immunolabeled for RHAMM or <bold>(B)</bold> live-labeled with the RHAMM antibody and imaged at the leading edge of the ECZ by confocal microscopy. These approaches revealed the presence of RHAMM <bold>(A)</bold> along cytoskeletal-structures (arrowhead) and <bold>(A,B)</bold> in the cells&#x2019; lamellipodial processes (arrow), as well as <bold>(B)</bold> as a cell-surface associated population with a fibrillar organization (arrowhead). Co-localization of cell surface of RHAMM with HA fibrils was demonstrated by live immunolabeling at D6 for both <bold>(C)</bold> RHAMM and <bold>(D)</bold> HA, imaged by confocal microscopy at the leading edge of the ECZ and <bold>(E)</bold> shown as merged images together with DAPI labeling of nuclei. <bold>(A,C-E)</bold> are projections created from collected confocal z-stacks with each optical plane at 0.49&#x20;&#xb5;m, <bold>(B)</bold> is a tiled confocal image. Magnification bars &#x3d; <bold>(A,C-E)</bold> 20&#xb5;m; <bold>(E)</bold> 50&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g006.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>Hyaluronic Acid and Receptor for Hyaluronan Mediated Motility Co-localize Along &#x3b1;SMA&#x2b; Stress Fibers in Myofibroblasts That Emerge Post-wounding</title>
<p>The localization of intracellular RHAMM in mesenchymal leader cells that have acquired a myofibroblast phenotype at D6 resembles that of actin stress fibers, suggesting its association with these cytoskeletal filaments (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>). As previous studies provide evidence that RHAMM can interact with actin filaments (<xref ref-type="bibr" rid="B7">Assmann et&#x20;al., 1999</xref>), we examined whether RHAMM function in myofibroblasts may involve its cooperation with &#x3b1;SMA&#x2b; stress fibers. For these studies, <italic>ex vivo</italic> mock cataract surgery cultures were fixed and permeabilized at D6&#x20;post-wounding, co-immunolabeled for &#x3b1;SMA and RHAMM, and labeled with a fluorescent-conjugated phalloidin to detect F-actin. Imaging was performed by confocal microscopy at the leading edge of the ECZ. The results confirm that RHAMM is localized along &#x3b1;SMA&#x2b; stress fibers and co-incident with F-actin (<xref ref-type="fig" rid="F7">Figures 7A&#x2013;D</xref>, arrows). In these same cells, RHAMM is also found in the tips of the lamellipodial protrusions extended by the myofibroblasts along the substrate at the leading edge (<xref ref-type="fig" rid="F7">Figures 7A,D</xref> arrowhead).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>HA/RHAMM localize along &#x3b1;SMA&#x2b; stress fibers of myofibroblasts. <italic>Ex vivo</italic> post-cataract surgery explant cultures at D6 were immunolabeled for either <bold>(A)</bold> RHAMM or <bold>(E)</bold> HA and each immunolabeled for <bold>(B,F)</bold> &#x3b1;SMA, and <bold>(C,G)</bold> colabeled for F-actin with fluorescent conjugated phalloidin and imaged by confocal microscopy. <bold>(D)</bold> Merged image of RHAMM, &#x3b1;SMA and F-actin; <bold>(H)</bold> Merged image of HA, &#x3b1;SMA and F-actin. RHAMM and HA both were co-localize along &#x3b1;SMA&#x2b; stress fibers and were coincident with F-actin (arrows). HA and RHAMM were also localized to lamellipodial protrusions at the leading edge (arrowheads). All images are presented as projections from collected confocal z-stacks with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bars &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g007.tif"/>
</fig>
<p>Since HA can interact with RHAMM both outside and inside the cell (<xref ref-type="bibr" rid="B37">Hascall et&#x20;al., 2004</xref>), we investigated whether HA also localizes along &#x3b1;SMA&#x2b; stress fibers in the myofibroblasts at the leading edge of the ECZ at D6&#x20;post-wounding. For these studies, the wounded explant cultures were fixed and permeabilized prior to labeling for F-actin, &#x3b1;SMA and HA. Similar to RHAMM (<xref ref-type="fig" rid="F7">Figures 7A&#x2013;D</xref>), HA was localized along &#x3b1;SMA&#x2b; stress fibers (<xref ref-type="fig" rid="F7">Figures 7E&#x2013;H</xref>, arrows), as well as to lamellipodial protrusions of the myofibroblasts at the leading edge (<xref ref-type="fig" rid="F7">Figures 7E,H</xref>, arrowhead). These findings suggest that HA/RHAMM may have a role in regulating the contractile machinery of myofibroblasts.</p>
<p>Another cytoskeletal structure that RHAMM has been shown to associate with are the microtubules, an association that is both context-specific and cell cycle-dependent, often involving its presence at the spindle poles (<xref ref-type="bibr" rid="B7">Assmann et&#x20;al., 1999</xref>; <xref ref-type="bibr" rid="B106">Tolg et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B18">Chen et&#x20;al., 2014</xref>). <italic>Ex vivo</italic> cataract surgery explant cultures co-immunolabeled for <italic>&#x3b1;</italic>-tubulin and RHAMM at D2 and D3&#x20;post-wounding and imaged by confocal microscopy at the leading edge of the ECZ showed that while these cells have an extensive microtubule network there was no evidence of their co-localization with RHAMM (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). The most prominent localization of RHAMM in these cells was to their lamellipodia protrusions.</p>
</sec>
<sec id="s3-8">
<title>Novel Association of Receptor for Hyaluronan Mediated Motility With Vimentin in Leader Cell Lamellipodial Protrusions Post-wounding</title>
<p>Our studies show that in the mesenchymal cells at the leading edge of the ECZ post-cataract surgery wounding RHAMM was consistently localized to the tips of lamellipodial protrusions (<xref ref-type="fig" rid="F4">Figures 4B,E</xref>, <xref ref-type="fig" rid="F6">Figures 6A</xref>, <xref ref-type="fig" rid="F7">7A</xref>). This pattern of localization is similar to that of the intermediate filament protein vimentin shown in our previous studies (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). Importantly, we had discovered that blocking vimentin function impairs cell migration post-wounding and blocks the transition of mesenchymal leader cells to myofibroblasts (<xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). We investigated whether RHAMM could associate with vimentin at these leader cell lamellipodial protrusions. <italic>Ex vivo</italic> mock cataract surgery explant cultures were co-labeled for RHAMM and vimentin at D2&#x20;post-wounding and imaged at the leading edge of the ECZ by confocal microscopy. These studies revealed that RHAMM and vimentin were highly co-localized at the lamellipodial extensions extended along the substrate surface at the leading edge of the ECZ (<xref ref-type="fig" rid="F8">Figures 8A&#x2013;C</xref>, 8Ai-Ci, arrowhead). Co-localization was also observed along the vimentin cytoskeletal network (<xref ref-type="fig" rid="F8">Figure&#x20;8C</xref>, arrow). In addition, there were regions where punctate labeling of RHAMM was localized to the substrate surface (<xref ref-type="fig" rid="F8">Figure&#x20;8A</xref>, open arrowhead, and <xref ref-type="sec" rid="s10">Supplementary Figure S2A</xref>,&#x20;Ai).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>RHAMM associates with vimentin at lamellipodial protrusions extended by mesenchymal leader cells. <bold>(A&#x2013;C)</bold> <italic>Ex vivo</italic> lens post-wounding explant cultures at D2 were co-immunolabeled for <bold>(A)</bold> RHAMM and <bold>(B)</bold> vimentin, imaged by confocal microscopy at the leading edge of the ECZ, and <bold>(C)</bold> shown as a merged image. Boxed regions in <bold>(A&#x2013;C)</bold> are shown at higher magnification in <bold>(A<italic>i</italic>-C<italic>i</italic>)</bold>. The images show significant co-localization of RHAMM and vimentin in the lamellipodial extensions (arrowhead) of the mesenchymal cells at the leading edge of the ECZ. RHAMM was also co-localized with to the vimentin cytoskeletal network (arrow) and detected as puncta along the substrate (open arrowhead). <bold>(D,E)</bold> PLA was performed at D2&#x20;post-mock cataract surgery wounding for <bold>(D)</bold> RHAMM and vimentin or <bold>(F)</bold> HA and vimentin to determine if there was a near-neighbor association (within 40&#xa0;nm or less) between these molecules and imaged by confocal microscopy at the leading edge of the ECZ. <bold>(E,G)</bold> shows the PLA finding together with co-labeling for F-actin. The results provides evidence of a complex consisting of HA, RHAMM and vimentin in leader cell lamellipodial protrusions. All images are presented as projections from collected confocal z-stacks with each optical plane at 0.49&#xa0;&#xb5;m. Magnification bars &#x3d; 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g008.tif"/>
</fig>
<p>To further investigate this discovery that RHAMM is colocalized with vimentin, we used the Proximal Ligation Assay (PLA), an <italic>in-situ</italic> assay that identifies protein-protein interactions within 40&#xa0;nm. PLA was performed on the explant cultures at D2&#x20;post-wounding with antibodies to vimentin and RHAMM, and the cultures post-labeled for F-actin. The results revealed that there is a close association between RHAMM and vimentin at the lamellipodial protrusions of cells at the leading edge of the ECZ (<xref ref-type="fig" rid="F8">Figures 8D,E</xref>). These are the first studies that link RHAMM function to the vimentin intermediate filament cytoskeleton. Since HA was also found enriched within the membrane protrusions of the cells at the leading edge of the ECZ (<xref ref-type="fig" rid="F7">Figure&#x20;7E</xref>), we examined the potential link between HA and RHAMM by PLA. The results also showed a close association between RHAMM and HA that is specific to the cell protrusions of the cells at the leading edge of the ECZ (<xref ref-type="fig" rid="F8">Figures 8F,G</xref>). These were the same sites as there is a positive PLA signal for RHAMM and vimentin. These findings suggest that the lamellipodial protrusions of the leader cells are enriched with a HA/RHAMM/vimentin complex. Since our previous studies showed that vimentin plays a role in mediating leader cell transition to a myofibroblast phenotype post-mock cataract surgery wounding (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>), our new findings suggest that this function is likely to be coordinated with HA/RHAMM.</p>
</sec>
<sec id="s3-9">
<title>Blocking Hyaluronic Acid Synthesis Prevents Leader Cell Production of a Pro-fibrotic Provisional Matrix, Suppresses Their Migration and Blocks Their Transition to an &#x3b1;SMA&#x2b; Myofibroblast Phenotype</title>
<p>Our findings showed that HA is an integral component of the FN-EDA/collagen I provisional matrix that is organized by the mesenchymal leader cells as they migrate across the ECZ in response to lens wounding. Here, they express RHAMM and CD44 with different patterns of localization, each of which co-localizes with HA. In addition to promoting processes like migration that are essential to wound repair, microenvironments rich in FN-EDA and collagen I are also considered pro-fibrotic (<xref ref-type="bibr" rid="B80">Muro et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B12">Bhattacharyya et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B39">Herrera et&#x20;al., 2018</xref>). Their organization in a wound environment has been linked to the presence of HA (<xref ref-type="bibr" rid="B8">Assun&#xe7;&#xe3;o et&#x20;al., 2021</xref>). Therefore, we performed functional studies to determine the impact of the HA synthesis inhibitor 4-MU on the assembly of these matrix proteins in the ECZ, the migration of the mesenchymal leader cells and their associated lens epithelium across the ECZ and the appearance of myofibroblasts at the leading edge. For these studies, wounded lens mock cataract surgery explant cultures were exposed to the HA synthesis inhibitor 4-MU or the vehicle DMSO from D1 through D3&#x20;post-injury. D3 is the time when the mesenchymal cells at the leading edge have acquired a myofibroblast phenotype. Confocal microscopy imaging was performed following immunolabeling for FN-EDA (<xref ref-type="fig" rid="F9">Figures 9A&#x2013;D</xref>), collagen I (with an antibody that recognizes both pro-collagen I and collagen I) (<xref ref-type="fig" rid="F9">Figures 9E&#x2013;H</xref>) and &#x3b1;SMA&#x2b; (<xref ref-type="fig" rid="F9">Figures 9I&#x2013;L</xref>). The results showed that blocking HA synthesis with 4-MU prevented the assembly of both FN-EDA and collagen I matrices in the extracellular microenvironment of the mesenchymal leader cells. Blocking HA expression also blocked the transition of the mesenchymal leader cells to an &#x3b1;SMA&#x2b; myofibroblast phenotype. The prevention of this key hallmark of fibrosis is likely the direct result of the failure to assemble a profibrotic ECM. As HA/RHAMM also has key roles in promoting cell migration post-wounding, we examined the impact of the absence of this provisional matrix microenvironment in the ECZ microenvironment. The wounded explant cultures were exposed to the HA synthesis inhibitor 4-MU or their vehicle DMSO from D1 through D3&#x20;post-injury and examined by phase contrast microscopy (<xref ref-type="fig" rid="F10">Figure&#x20;10</xref>), and with time-lapse microscopy imaging (<xref ref-type="sec" rid="s10">Supplementary Movies S1, S2</xref>). Blocking HA synthesis greatly suppressed but did not block cell migration across the ECZ. These results suggest the HA plays an essential role in the formation of the provisional matrix in response to cataract surgery wounding that is required for both the promotion of cell migration and the development of fibrosis.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Blocking HA expression with 4-MU prevents assembly of a FN-EDA, collagen I rich provisional matrix and the transition of mesenchymal leader cells to a myofibroblast phenotype in response to wounding. <bold>(A&#x2013;L)</bold> <italic>Ex vivo</italic> cataract surgery explants were treated in culture from D1-D3 post-wounding with <bold>(C,D,G,H,K,L)</bold> the HA synthesis inhibitor 4-MU (400&#xa0;&#xb5;M) or <bold>(A,B,E,F,I,J)</bold> its vehicle DMSO, immunolabeled for <bold>(A&#x2013;D)</bold> FN-EDA <bold>(E&#x2013;H)</bold> collagen I or <bold>(I&#x2013;L)</bold> &#x3b1;SMA, co-labeled with DAPI, and imaged by confocal microscopy at the leading edge of the ECZ. Blocking expression of HA with 4-MU prevented leader cell assembly of a FN-EDA and Collagen I rich ECM microenvironment and prevented the emergence of &#x3b1;SMA&#x2b; myofibroblasts. Images are presented as projections from collected confocal z-stacks with each optical plane at 0.33&#xa0;&#xb5;m. Magnification bars &#x3d; 20&#xa0;&#xb5;m. The data presented represents at least 3 independent studies.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g009.tif"/>
</fig>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Blocking HA synthesis inhibits migration of cells within the ECZ. Ex&#x20;vivo post-cataract surgery explants were treated in culture from D1-D3 post-wounding with the HA synthesis inhibitor 4-MU (400&#xa0;&#xb5;M) or its vehicle DMSO. Phase images of the ECZ were captured 48hrs post-treatment on D3, revealing that 4-MU treatment reduced cell migration in the ECZ region compared to vehicle controls. White dotted line marks the border between the explant and the ECZ.</p>
</caption>
<graphic xlink:href="fcell-10-862423-g010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>A provisional matrix is formed in the wound microenvironment to promote cell migration across the injured area and close the wound (<xref ref-type="bibr" rid="B10">Barker and Engler 2017</xref>; <xref ref-type="bibr" rid="B21">Chester and Brown 2017</xref>; <xref ref-type="bibr" rid="B47">Johnson et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B71">McKay et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B24">Das et&#x20;al., 2021</xref>). In addition to serving as the substrate for movement of the wound-activated cells, this ECM can also be a sink for cytokines and growth factors that impact both cell movement and cell fate (<xref ref-type="bibr" rid="B95">Schultz and Wysocki 2009</xref>; <xref ref-type="bibr" rid="B119">Wilgus 2012</xref>; <xref ref-type="bibr" rid="B31">Frangogiannis 2017</xref>). Induction of many of the components of this provisional matrix post-wounding, including collagen I, fibronectin and HA, have been linked to activation of TGF&#x3b2; (<xref ref-type="bibr" rid="B90">Roberts et&#x20;al., 1986</xref>; <xref ref-type="bibr" rid="B42">Ignotz et&#x20;al., 1987</xref>; <xref ref-type="bibr" rid="B2">Albeiroti et&#x20;al., 2015</xref>). These matrix proteins provide ligands for receptors expressed on the cell surface that participate directly in cell adhesion and in the transmission of signals from the matrix that promote cell migration. In the post-wounding microenvironment, fibronectin, collagen I, HA and TGF&#x3b2; are all also linked to promoting fibrosis, a pathological outcome to their function in wound repair (<xref ref-type="bibr" rid="B56">Leask and Abraham 2004</xref>; <xref ref-type="bibr" rid="B2">Albeiroti et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B117">Walraven and Hinz 2018</xref>). The post-cataract surgery fibrotic disease PCO is characterized by both cell migration onto the cell-denuded posterior lens capsule and the subsequent appearance of myofibroblasts (<xref ref-type="bibr" rid="B100">Spalton 1999</xref>; <xref ref-type="bibr" rid="B121">Wormstone et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B120">Wormstone and Eldred 2016</xref>; <xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B122">Wormstone et&#x20;al., 2021</xref>). Collagen I, fibronectin and TGF&#x3b2; have been linked to fibrosis and fibrotic PCO (<xref ref-type="bibr" rid="B110">Uitto et&#x20;al., 1982</xref>; <xref ref-type="bibr" rid="B96">Serini et&#x20;al., 1998</xref>; <xref ref-type="bibr" rid="B32">Gabbiani 2003</xref>; <xref ref-type="bibr" rid="B80">Muro et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B39">Herrera et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B11">Basta et&#x20;al., 2021</xref>). However, the only evidence that HA may play a role in induction of fibrosis following lens wounding comes from a study with a canine <italic>ex vivo</italic> cataract surgery model where the inclusion of exogenous HA promoted fibrotic PCO (<xref ref-type="bibr" rid="B17">Chandler et&#x20;al., 2012</xref>). Our findings now showed that HA is produced in response to cataract surgery wounding and that its presence in the lens wound environment promotes cell migration and also creates conditions permissive to transitioning the cells involved in lens wound repair to a myofibroblast phenotype.</p>
<p>These findings support developing a therapeutic approach targeting HA production to mitigate the development of the lens fibrotic disease PCO. The use of a small molecular inhibitor to block HA production at the time of cataract surgery, applied directly to the post-cataract surgery lens capsular bag is expected to have limited effects on surrounding eye tissues. The inhibitor used in our study, 4-MU, blocks global HA synthesis by depleting cellular pools of the HAS substrate UDP- glucuronic acid (UDP-GlcUA), which is required for HA synthesis (<xref ref-type="bibr" rid="B48">Kakizaki et&#x20;al., 2004</xref>). 4-MU also was shown to decrease HAS mRNA levels (<xref ref-type="bibr" rid="B55">Kultti et&#x20;al., 2009</xref>). Therefore, treatment with 4-MU will interfere with the function of all three HA synthases, HAS1, HAS2 and HAS3, with the potential to impact both fibrotic and regenerative repair. A better approach would be to identify and target the specific injury activated HAS(s) lead to the lens fibrotic phenotype post-cataract surgery wounding. A likely candidate is HAS2, which is linked to driving fibrosis in other tissues, such as the liver and lung (<xref ref-type="bibr" rid="B62">Li et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B124">Yang et&#x20;al., 2019</xref>). The <italic>ex vivo</italic> post-cataract surgery model will provide an ideal reductionist model for future studies in which to determine the function of individual HASs in promoting the fibrotic outcome to cataract surgery wounding.</p>
<p>In studies with the <italic>ex vivo</italic> chick mock cataract surgery explant cultures and human post-cataract surgery explant cultures we now identify the mesenchymal leader cells that rapidly populate the wound edges of the explant and acquire a myofibroblast phenotype as tissue resident immune cells (<xref ref-type="bibr" rid="B76">Menko et&#x20;al., 2021</xref>). Our earlier studies demonstrated that this mesenchymal leader cell population directs the wounded lens epithelium to migrate off the capsule onto and across the surrounding tissue culture substrate (<xref ref-type="bibr" rid="B114">Walker et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B115">Walker et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B14">Bleaken et&#x20;al., 2016</xref>), and that their acquisition of myofibroblast phenotype continues to expand over time (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). We show that the properties of these resident immune cells includes expression of CD45, MHCII, and the HA receptor CD44 (<xref ref-type="bibr" rid="B76">Menko et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B112">Walker and Menko 2021</xref>). The interaction between CD44, a hallmark of the leader cell population, and HA is considered a driving force in the recruitment and migration of immune cells (<xref ref-type="bibr" rid="B70">McDonald and Kubes 2015</xref>; <xref ref-type="bibr" rid="B81">Nagy et&#x20;al., 2019</xref>).</p>
<p>Studies of the cataract surgery response in CD44 knockout mice shows that the development of fibrotic PCO is not impaired in the absence of this HA receptor (<xref ref-type="bibr" rid="B26">Desai et&#x20;al., 2010</xref>). Our new findings suggest that this role is played by the HA receptor RHAMM. Its pattern of localization in the mesenchymal leader cells post-cataract surgery wounding to lamellipodia processes extended at the leading edge, and along actin stress fibers are consistent with functions in leader cell migration, transition to a myofibroblast, and myofibroblast persistence in fibrosis. Since HA signaling through RHAMM can mediate the induction of cell migration by TGF&#x3b2; (<xref ref-type="bibr" rid="B93">Samuel et&#x20;al., 1993</xref>), it is possible that RHAMM function is coordinated with TGF&#x3b2; in promoting a fibrotic outcome. The intracellular population of RHAMM have distinct, and important functions that include roles as a transcriptional regulator (<xref ref-type="bibr" rid="B72">Meier et&#x20;al., 2014</xref>) and in its association with different elements of the cytoskeleton (<xref ref-type="bibr" rid="B7">Assmann et&#x20;al., 1999</xref>). In mitotic cells, RHAMM is a stabilizer of the spindle poles and there is evidence that of a stabilizing role along microtubules and actin filaments (<xref ref-type="bibr" rid="B68">Maxwell et&#x20;al., 2003</xref>). While we find no evidence of a microtubule association in the mesenchymal leader cells post-cataract surgery wounding, we found that RHAMM is localized along the &#x3b1;SMA&#x2b; stress fibers of myofibroblasts during the later culture times of our study. A recent study shows that Hyaluronidase-2 (HYAL2) localizes along F-actin rich stress fibers and associates with &#x3b1;SMA in TGF&#x3b2;-induced myofibroblasts (<xref ref-type="bibr" rid="B78">Midgley et&#x20;al., 2020</xref>). In this study, HYAL-2 is shown to interact with and activate RhoA to regulate myofibroblast migration, contraction, and expression of pro-fibrotic genes such as FN and collagen I (<xref ref-type="bibr" rid="B78">Midgley et&#x20;al., 2020</xref>). The initial localization of RHAMM to lamellipodial extensions of the mesenchymal cells that locate to the leading-edge post-wounding in our studies suggests that RHAMM may be concentrated at integrin focal adhesion complexes, sites where active Rho/ROCK signaling involved in inducing the assembly of both the focal adhesions and the actin stress fibers that directly link to them. We speculate that RHAMM localization to these sites may play a role in the initial formation of actin stress fibers, and the mechanotransduction signaling involved in acquisition of a myofibroblast phenotype. Furthermore, localization of RHAMM along &#x3b1;SMA&#x2b; stress fibers formed after the transition of the leader cells to myofibroblasts may function in a similar manner to HYAL2 to regulate their contractile, pro-fibrotic functions. Rho-Rho kinase signaling is critical to the acquisition of a myofibroblast phenotype in the lens (<xref ref-type="bibr" rid="B53">Korol et&#x20;al., 2016</xref>) and for capsule contraction linked to fibrosis in a mouse lens injury model (<xref ref-type="bibr" rid="B41">Ichikawa et&#x20;al., 2020</xref>). Our new findings that RHAMM localizes initially to leader cells in regions rich in integrin focal adhesion complexes and then along the &#x3b1;SMA&#x2b; contractile machinery after their transition to myofibroblasts open promising new areas of study for investigating whether there is a functional link between RHAMM and Rho-ROCK signaling in response to cataract surgery wounding. RHAMM&#x2019;s distinct extracellular and intracellular subcellular patterns observed with the <italic>ex vivo</italic> post-cataract surgery cultures suggest that RHAMM plays multiple location-specific functions to mediate the fibrotic outcome to cataract surgery wounding.</p>
<p>Our PLA studies provide the first evidence that the localization of RHAMM to the lamellipodial processes of mesenchymal leader cells post-wounding reflects its presence in a complex together with both HA and vimentin. Vimentin is an intermediate filament protein with essential functions in both cell migration and wound closure (<xref ref-type="bibr" rid="B101">SundarRaj et&#x20;al., 1992</xref>; <xref ref-type="bibr" rid="B28">Eckes et&#x20;al., 1998</xref>; <xref ref-type="bibr" rid="B29">Eckes et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B73">Mendez et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>). While it is best known as a cytoskeletal filamentous network that provides cells with resistance to mechanical stresses, non-filamentous forms of vimentin have been identified with both intracellular and extracellular functions (<xref ref-type="bibr" rid="B79">Mor-Vaknin et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B104">Teshigawara et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B74">Menko et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B98">Shigyo et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B97">Shigyo and Tohda 2016</xref>; <xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). The extracellular form of vimentin has been linked to the activation of latent TGF&#x3b2; (<xref ref-type="bibr" rid="B84">Nishida et&#x20;al., 2009</xref>). Our previous studies show that extracellular vimentin is produced in response to cataract surgery wounding and that an extracellular, cell surface-linked, population of vimentin is involved in signaling the transition of the mesenchymal leader cells to a myofibroblast phenotype (<xref ref-type="bibr" rid="B116">Walker et&#x20;al., 2018</xref>). The <italic>ex vivo</italic> lens-wound explant model closely parallels the complexity of typical wound environments, including the organization of an HA-containing provisional matrix that is formed to promote cell migration and close the wound that also can induce repair-modulating wound-response cells to acquire a myofibroblast phenotype. Our discoveries, including that of an HA/extracellular vimentin/RHAMM axis that is likely linked to both cell migration and the transition of mesenchymal leader cells to myofibroblasts provides a previously unknown key to the mysteries of the antithetical outcomes of healing and fibrosis in the wound environment.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by The Institutional Animal Care and Use Committee (IACUC) at Thomas Jefferson University (Philadelphia,&#x20;PA).</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>ASM and JLW contributed to the conception and design of the study. AR and JLW performed experiments for the manuscript. ASM and JLW contributed to writing and editing the manuscript. All authors read and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was funded by National Institute of Health grant EY021784 to&#x20;ASM.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We would like to thank Ramon Ortega-Alvarez for his technical assistance.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2022.862423/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2022.862423/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image2.TIF" id="SM1" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.TIF" id="SM2" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video2.MP4" id="SM3" mimetype="application/MP4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video1.MP4" id="SM4" mimetype="application/MP4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.docx" id="SM5" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abatangelo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vindigni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Avruscio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pandis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brun</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hyaluronic Acid: Redefining its Role</article-title>. <source>Cells</source> <volume>9</volume> (<issue>7</issue>), <fpage>1743</fpage>. <pub-id pub-id-type="doi">10.3390/cells9071743</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albeiroti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soroosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de la Motte</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Hyaluronan&#x27;s Role in Fibrosis: A Pathogenic Factor or a Passive Player?</article-title> <source>Biomed. Res. Int.</source> <volume>2015</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1155/2015/790203</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amorim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Extracellular Matrix Mimics Using Hyaluronan-Based Biomaterials</article-title>. <source>Trends Biotechnol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2020.06.003</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreichenko</surname>
<given-names>I. N.</given-names>
</name>
<name>
<surname>Tsitrina</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Fokin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Gabdulkhakova</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Maltsev</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Perelman</surname>
<given-names>G. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization</article-title>. <source>Ijms</source> <volume>20</volume> (<issue>24</issue>), <fpage>6301</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20246301</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arandjelovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ravichandran</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Phagocytosis of Apoptotic Cells in Homeostasis</article-title>. <source>Nat. Immunol.</source> <volume>16</volume> (<issue>9</issue>), <fpage>907</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3253</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ardain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marakalala</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Tissue&#x2010;Resident Innate Immunity in the Lung</article-title>. <source>Immunology</source> <volume>159</volume> (<issue>3</issue>), <fpage>245</fpage>&#x2013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1111/imm.13143</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assmann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>I. R.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>The Intracellular Hyaluronan Receptor RHAMM/IHABP Interacts with Microtubules and Actin Filaments</article-title>. <source>J.&#x20;Cel. Sci.</source> <volume>112</volume> (<issue>Pt 22</issue>), <fpage>3943</fpage>&#x2013;<lpage>3954</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.112.22.3943</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assun&#xe7;&#xe3;o</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yiu</surname>
<given-names>C. H. K.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ker</surname>
<given-names>D. F. E.</given-names>
</name>
<name>
<surname>Tuan</surname>
<given-names>R. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Hyaluronic Acid Drives Mesenchymal Stromal Cell-Derived Extracellular Matrix Assembly by Promoting Fibronectin Fibrillogenesis</article-title>. <source>J.&#x20;Mater. Chem. B</source> <volume>9</volume> (<issue>35</issue>), <fpage>7205</fpage>&#x2013;<lpage>7215</lpage>. <pub-id pub-id-type="doi">10.1039/d1tb00268f</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aya</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Hyaluronan in Wound Healing: Rediscovering a Major Player</article-title>. <source>Wound Repair Regen.</source> <volume>22</volume> (<issue>5</issue>), <fpage>579</fpage>&#x2013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.12214</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Provisional Matrix: Setting the Stage for Tissue Repair Outcomes</article-title>. <source>Matrix Biol.</source> <volume>60-61</volume>, <fpage>1</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2017.04.003</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basta</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Local Wound Environment Is a Key Determinant of the Outcome of TGF&#x3b2; Signaling on the Fibrotic Response of CD44<sup>&#x2b;</sup> Leader Cells in an <italic>Ex Vivo</italic> post-cataract-surgery Model</article-title>. <source>Exp. Eye Res.</source> <volume>213</volume>, <fpage>108829</fpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2021.108829</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tamaki</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hinchcliff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoover</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Getsios</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Fibronectin EDA Promotes Chronic Cutaneous Fibrosis through Toll-Like Receptor Signaling</article-title>. <source>Sci. Transl. Med.</source> <volume>6</volume> (<issue>232</issue>), <fpage>232ra250</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3008264</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bissell</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Thinking in Three Dimensions: Discovering Reciprocal Signaling between the Extracellular Matrix and Nucleus and the Wisdom of Microenvironment and Tissue Architecture</article-title>. <source>MBoC</source> <volume>27</volume> (<issue>21</issue>), <fpage>3192</fpage>&#x2013;<lpage>3196</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E16-06-0440</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bleaken</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cells Activated for Wound Repair Have the Potential to Direct Collective Invasion of an Epithelium</article-title>. <source>MBoC</source> <volume>27</volume> (<issue>3</issue>), <fpage>451</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E15-09-0615</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyman</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Conrad</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tonel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gilliet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nestle</surname>
<given-names>F. O.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>The Pathogenic Role of Tissue-Resident Immune Cells in Psoriasis</article-title>. <source>Trends Immunol.</source> <volume>28</volume> (<issue>2</issue>), <fpage>51</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2006.12.005</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bremer</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Rasquin</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Histochemical Localization of Hyaluronic Acid in Vitreous during Embryonic Development</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>39</volume> (<issue>12</issue>), <fpage>2466</fpage>&#x2013;<lpage>2469</lpage>. </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandler</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Haeussler</surname>
<given-names>D. J.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Gemensky-Metzler</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Wilkie</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Lutz</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Induction of Posterior Capsule Opacification by Hyaluronic Acid in an <italic>Ex Vivo</italic> Model</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>53</volume> (<issue>4</issue>), <fpage>1835</fpage>&#x2013;<lpage>1845</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.11-8735</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nemirovsky</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fleisch</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Spatial Regulation of Aurora A Activity during Mitotic Spindle Assembly Requires RHAMM to Correctly Localize TPX2</article-title>. <source>Cell Cycle</source> <volume>13</volume> (<issue>14</issue>), <fpage>2248</fpage>&#x2013;<lpage>2261</lpage>. <pub-id pub-id-type="doi">10.4161/cc.29270</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karnad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>J.&#x20;W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Biology and Role of CD44 in Cancer Progression: Therapeutic Implications</article-title>. <source>J.&#x20;Hematol. Oncol.</source> <volume>11</volume> (<issue>1</issue>), <fpage>64</fpage>. <pub-id pub-id-type="doi">10.1186/s13045-018-0605-5</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Role of CD44 in Pathological Angiogenesis</article-title>. <source>FASEB j.</source> <volume>34</volume> (<issue>10</issue>), <fpage>13125</fpage>&#x2013;<lpage>13139</lpage>. <pub-id pub-id-type="doi">10.1096/fj.202000380RR</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chester</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Role of Biophysical Properties of Provisional Matrix Proteins in Wound Repair</article-title>. <source>Matrix Biol.</source> <volume>60-61</volume>, <fpage>124</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2016.08.004</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correa&#x2010;Gallegos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rinkevich</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cutting into Wound Repair</article-title>. <source>FEBS J.</source> <pub-id pub-id-type="doi">10.1111/febs.16078</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Longoria</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>DeLisser</surname>
<given-names>H. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The Receptor for Hyaluronan-Mediated Motility (CD168) Promotes Inflammation and Fibrosis after Acute Lung Injury</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>255</fpage>&#x2013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.08.002</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lejeune</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Eyckmans</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Extracellular Matrix Alignment Directs Provisional Matrix Assembly and Three Dimensional Fibrous Tissue Closure</article-title>. <source>Tissue Eng. A</source> <volume>27</volume> (<issue>23-24</issue>), <fpage>1447</fpage>&#x2013;<lpage>1457</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2020.0332</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>J.&#x20;E.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>P. R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Tissue-Resident Macrophages</article-title>. <source>Nat. Immunol.</source> <volume>14</volume> (<issue>10</issue>), <fpage>986</fpage>&#x2013;<lpage>995</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2705</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Simirskii</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>CD44 Expression Is Developmentally Regulated in the Mouse Lens and Increases in the Lens Epithelium after Injury</article-title>. <source>Differentiation</source> <volume>79</volume> (<issue>2</issue>), <fpage>111</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.diff.2009.09.004</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dicker</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Gurski</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Pradhan-Bhatt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Witt</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Farach-Carson</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Hyaluronan: a Simple Polysaccharide with Diverse Biological Functions</article-title>. <source>Acta Biomater.</source> <volume>10</volume> (<issue>4</issue>), <fpage>1558</fpage>&#x2013;<lpage>1570</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2013.12.019</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dogic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Colucci-Guyon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Maniotis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ingber</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Impaired Mechanical Stability, Migration and Contractile Capacity in Vimentin-Deficient Fibroblasts</article-title>. <source>J.&#x20;Cel Sci.</source> <volume>111</volume> (<issue>Pt 13</issue>), <fpage>1897</fpage>&#x2013;<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.111.13.1897</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Colucci-Guyon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Smola</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nodder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Babinet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Krieg</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Impaired Wound Healing in Embryonic and Adult Mice Lacking Vimentin</article-title>. <source>J.&#x20;Cel. Sci.</source> <volume>113</volume> (<issue>Pt 13</issue>), <fpage>2455</fpage>&#x2013;<lpage>2462</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.113.13.2455</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evanko</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Wight</surname>
<given-names>T. N.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Intracellular Localization of Hyaluronan in Proliferating Cells</article-title>. <source>J.&#x20;Histochem. Cytochem.</source> <volume>47</volume> (<issue>10</issue>), <fpage>1331</fpage>&#x2013;<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.1177/002215549904701013</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frangogiannis</surname>
<given-names>N. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Extracellular Matrix in Myocardial Injury, Repair, and Remodeling</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>127</volume> (<issue>5</issue>), <fpage>1600</fpage>&#x2013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1172/jci87491</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabbiani</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>The Myofibroblast in Wound Healing and Fibrocontractive Diseases</article-title>. <source>J.&#x20;Pathol.</source> <volume>200</volume> (<issue>4</issue>), <fpage>500</fpage>&#x2013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1002/path.1427</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garantziotis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Savani</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hyaluronan Biology: A Complex Balancing Act of Structure, Function, Location and Context</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2019.02.002</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginhoux</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guilliams</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Tissue-Resident Macrophage Ontogeny and Homeostasis</article-title>. <source>Immunity</source> <volume>44</volume> (<issue>3</issue>), <fpage>439</fpage>&#x2013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.024</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govindaraju</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shetye</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Monslow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pur&#xe9;</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>CD44-Dependent Inflammation, Fibrogenesis, and Collagenolysis Regulates Extracellular Matrix Remodeling and Tensile Strength during Cutaneous Wound Healing</article-title>. <source>Matrix Biol.</source> <volume>75-76</volume>, <fpage>314</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.06.004</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardwick</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hoare</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hohn</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hook</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Molecular Cloning of a Novel Hyaluronan Receptor that Mediates Tumor Cell Motility</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>117</volume> (<issue>6</issue>), <fpage>1343</fpage>&#x2013;<lpage>1350</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.117.6.1343</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hascall</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Majors</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>De La Motte</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Evanko</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Drazba</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Intracellular Hyaluronan: a New Frontier for Inflammation?</article-title> <source>Biochim. Biophys. Acta (Bba) - Gen. Subjects</source> <volume>1673</volume> (<issue>1-2</issue>), <fpage>3</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2004.02.013</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heldin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Kolliopoulos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Skandalis</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Regulation of Hyaluronan Biosynthesis and Clinical Impact of Excessive Hyaluronan Production</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>100</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.01.017</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Henke</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Bitterman</surname>
<given-names>P. B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Extracellular Matrix as a Driver of Progressive Fibrosis</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>128</volume> (<issue>1</issue>), <fpage>45</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1172/JCI93557</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Myofibroblasts</article-title>. <source>Exp. Eye Res.</source> <volume>142</volume>, <fpage>56</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2015.07.009</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>S.-I.</given-names>
</name>
<name>
<surname>Ichikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyajima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Saika</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inhibition of Rho Kinase Suppresses Capsular Contraction Following Lens Injury in Mice</article-title>. <source>Taiwan J.&#x20;Ophthalmol.</source> <volume>10</volume> (<issue>2</issue>), <fpage>100</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.4103/tjo.tjo_80_19</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ignotz</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Endo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Massagu&#xe9;</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Regulation of Fibronectin and Type I Collagen mRNA Levels by Transforming Growth Factor-Beta</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>262</volume> (<issue>14</issue>), <fpage>6443</fpage>&#x2013;<lpage>6446</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(18)48258-0</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inatani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanihara</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Proteoglycans in Retina</article-title>. <source>Prog. Retin. Eye Res.</source> <volume>21</volume> (<issue>5</issue>), <fpage>429</fpage>&#x2013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/s1350-9462(02)00009-5</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kimata</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Mammalian Hyaluronan Synthases</article-title>. <source>IUBMB Life (International Union Biochem. Mol. Biol. Life)</source> <volume>54</volume> (<issue>4</issue>), <fpage>195</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1080/15216540214929</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>P. W.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Hyaluronan in Tissue Injury and Repair</article-title>. <source>Annu. Rev. Cel Dev. Biol.</source> <volume>23</volume>, <fpage>435</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.cellbio.23.090506.123337</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shihan</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Lens Epithelial Cells Initiate an Inflammatory Response Following Cataract Surgery</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>59</volume> (<issue>12</issue>), <fpage>4986</fpage>&#x2013;<lpage>4997</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.18-25067</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Arif</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Lee-Sayer</surname>
<given-names>S. S. M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Hyaluronan and its Interactions with Immune Cells in the Healthy and Inflamed Lung</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <fpage>2787</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02787</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakizaki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takagaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Endo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kannagi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-methylumbelliferone</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>279</volume> (<issue>32</issue>), <fpage>33281</fpage>&#x2013;<lpage>33289</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M405918200</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karppinen</surname>
<given-names>S.-M.</given-names>
</name>
<name>
<surname>Heljasvaara</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gullberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tasanen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pihlajaniemi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Toward Understanding Scarless Skin Wound Healing and Pathological Scarring</article-title>. <source>F1000Res</source> <volume>8</volume>, <fpage>787</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.18293.1</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Vranka</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Acott</surname>
<given-names>T. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Inhibition of Hyaluronan Synthesis Reduces Versican and Fibronectin Levels in Trabecular Meshwork Cells</article-title>. <source>PLoS One</source> <volume>7</volume> (<issue>11</issue>), <fpage>e48523</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0048523</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Sheppard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>TGF-&#x3b2;1 Signaling and Tissue Fibrosis</article-title>. <source>Cold Spring Harb Perspect. Biol.</source> <volume>10</volume> (<issue>4</issue>), <fpage>a022293</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a022293</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chanmee</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Itano</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hyaluronan: Metabolism and Function</article-title>. <source>Biomolecules</source> <volume>10</volume> (<issue>11</issue>), <fpage>1525</fpage>. <pub-id pub-id-type="doi">10.3390/biom10111525</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korol</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taiyab</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>West-Mays</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>RhoA/ROCK Signaling Regulates TGF&#x3b2;-Induced Epithelial-Mesenchymal Transition of Lens Epithelial Cells through MRTF-A</article-title>. <source>Mol. Med.</source> <volume>22</volume>, <fpage>713</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.2119/molmed.2016.00041</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krolikoski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Monslow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pur&#xe9;</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The CD44-HA axis and Inflammation in Atherosclerosis: A Temporal Perspective</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>201</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.05.007</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kultti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pasonen-Sepp&#xe4;nen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jauhiainen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rilla</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>K&#xe4;rn&#xe4;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Py&#xf6;ri&#xe4;</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>4-Methylumbelliferone Inhibits Hyaluronan Synthesis by Depletion of Cellular UDP-Glucuronic Acid and Downregulation of Hyaluronan Synthase 2 and 3</article-title>. <source>Exp. Cel. Res.</source> <volume>315</volume> (<issue>11</issue>), <fpage>1914</fpage>&#x2013;<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2009.03.002</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leask</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>TGF&#x2010;&#x3b2; Signaling and the Fibrotic Response</article-title>. <source>FASEB j.</source> <volume>18</volume> (<issue>7</issue>), <fpage>816</fpage>&#x2013;<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-1273rev</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lech</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gr&#xf6;bmayr</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Weidenbusch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>H.-J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Tissues Use Resident Dendritic Cells and Macrophages to Maintain Homeostasis and to Regain Homeostasis upon Tissue Injury: the Immunoregulatory Role of Changing Tissue Environments</article-title>. <source>Mediators Inflamm.</source> <volume>2012</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1155/2012/951390</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee-Sayer</surname>
<given-names>S. S. M.</given-names>
</name>
<name>
<surname>Dougan</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sanderson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dosanjh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maxwell</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>CD44-mediated Hyaluronan Binding marks Proliferating Hematopoietic Progenitor Cells and Promotes Bone Marrow Engraftment</article-title>. <source>PLoS One</source> <volume>13</volume> (<issue>4</issue>), <fpage>e0196011</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0196011</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wendt</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Calve</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hyaluronic Acid, CD44 and RHAMM Regulate Myoblast Behavior during Embryogenesis</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>236</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.08.008</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levesque</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>B. F.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>
<italic>In Vitro</italic> culture of Human Peripheral Blood Monocytes Induces Hyaluronan Binding and Up-Regulates Monocyte Variant CD44 Isoform Expression</article-title>. <source>J.&#x20;Immunol.</source> <volume>156</volume> (<issue>4</issue>), <fpage>1557</fpage>&#x2013;<lpage>1565</lpage>. </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Severe Lung Fibrosis Requires an Invasive Fibroblast Phenotype Regulated by Hyaluronan and CD44</article-title>. <source>J.&#x20;Exp. Med.</source> <volume>208</volume> (<issue>7</issue>), <fpage>1459</fpage>&#x2013;<lpage>1471</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20102510</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Monterrosa Mena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Hyaluronan Synthase 2 Regulates Fibroblast Senescence in Pulmonary Fibrosis</article-title>. <source>Matrix Biol.</source> <volume>55</volume>, <fpage>35</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2016.03.004</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Grinstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Diversity and Versatility of Phagocytosis: Roles in Innate Immunity, Tissue Remodeling, and Homeostasis</article-title>. <source>Front. Cel. Infect. Microbiol.</source> <volume>7</volume>, <fpage>191</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00191</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logan</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Induction of Immune Surveillance of the Dysmorphogenic Lens</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>16235</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-16456-5</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Werb</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Extracellular Matrix Degradation and Remodeling in Development and Disease</article-title>. <source>Cold Spring Harbor Perspect. Biol.</source> <volume>3</volume> (<issue>12</issue>), <fpage>a005058</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a005058</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>1173</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01173</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masopust</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Soerens</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tissue-Resident T&#x20;Cells and Other Resident Leukocytes</article-title>. <source>Annu. Rev. Immunol.</source> <volume>37</volume>, <fpage>521</fpage>&#x2013;<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053214</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maxwell</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Keats</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Crainie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>RHAMM Is a Centrosomal Protein that Interacts with Dynein and Maintains Spindle Pole Stability</article-title>. <source>MBoC</source> <volume>14</volume> (<issue>6</issue>), <fpage>2262</fpage>&#x2013;<lpage>2276</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e02-07-0377</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maytin</surname>
<given-names>E. V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Hyaluronan: More Than Just a Wrinkle Filler</article-title>. <source>Glycobiology</source> <volume>26</volume> (<issue>6</issue>), <fpage>553</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cww033</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kubes</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Interactions between CD44 and Hyaluronan in Leukocyte Trafficking</article-title>. <source>Front. Immunol.</source> <volume>6</volume>, <fpage>68</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00068</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Karamichos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hutcheon</surname>
<given-names>A. E. K.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zieske</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Corneal Epithelial-Stromal Fibroblast Constructs to Study Cell-Cell Communication <italic>In Vitro</italic>
</article-title>. <source>Bioengineering</source> <volume>6</volume> (<issue>4</issue>), <fpage>110</fpage>. <pub-id pub-id-type="doi">10.3390/bioengineering6040110</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spitschak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abshagen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mor</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Wolkenhauer</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Association of RHAMM with E2F1 Promotes Tumour Cell Extravasation by Transcriptional Up-Regulation of Fibronectin</article-title>. <source>J.&#x20;Pathol.</source> <volume>234</volume> (<issue>3</issue>), <fpage>351</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1002/path.4400</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Vimentin Induces Changes in Cell Shape, Motility, and Adhesion during the Epithelial to Mesenchymal Transition</article-title>. <source>FASEB j.</source> <volume>24</volume> (<issue>6</issue>), <fpage>1838</fpage>&#x2013;<lpage>1851</lpage>. <pub-id pub-id-type="doi">10.1096/fj.09-151639</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Bleaken</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Libowitz</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stepp</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A central Role for Vimentin in Regulating Repair Function during Healing of the Lens Epithelium</article-title>. <source>MBoC</source> <volume>25</volume> (<issue>6</issue>), <fpage>776</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E12-12-0900</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Stepp</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Fibrosis: Shared Lessons from the Lens and Cornea</article-title>. <source>Anat. Rec.</source> <volume>303</volume> (<issue>6</issue>), <fpage>1689</fpage>&#x2013;<lpage>1702</lpage>. <pub-id pub-id-type="doi">10.1002/ar.24088</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>DeDreu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Resident Immune Cells of the Avascular Lens: Mediators of the Injury and Fibrotic Response of the Lens</article-title>. <source>FASEB j.</source> <volume>35</volume> (<issue>4</issue>), <fpage>e21341</fpage>. <pub-id pub-id-type="doi">10.1096/fj.202002200R</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Involvement of Hyaluronan in Regulation of Fibroblast Phenotype</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>282</volume> (<issue>35</issue>), <fpage>25687</fpage>&#x2013;<lpage>25697</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M700773200</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Midgley</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Khalid</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Chavez</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Hyaluronidase-2 Regulates RhoA Signaling, Myofibroblast Contractility, and Other Key Profibrotic Myofibroblast Functions</article-title>. <source>Am. J.&#x20;Pathol.</source> <volume>190</volume> (<issue>6</issue>), <fpage>1236</fpage>&#x2013;<lpage>1255</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2020.02.012</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mor-Vaknin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Punturieri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sitwala</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Markovitz</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Vimentin Is Secreted by Activated Macrophages</article-title>. <source>Nat. Cel Biol.</source> <volume>5</volume> (<issue>1</issue>), <fpage>59</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/ncb898</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muro</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Moretti</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Atrasz</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Wilke</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>An Essential Role for Fibronectin Extra Type III Domain A in Pulmonary Fibrosis</article-title>. <source>Am. J.&#x20;Respir. Crit. Care Med.</source> <volume>177</volume> (<issue>6</issue>), <fpage>638</fpage>&#x2013;<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200708-1291OC</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kuipers</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kaber</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bollyky</surname>
<given-names>P. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hyaluronan in Immune Dysregulation and Autoimmune Diseases</article-title>. <source>Matrix Biol.</source> <volume>78-79</volume>, <fpage>292</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.03.022</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Bissell</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Modeling Dynamic Reciprocity: Engineering Three-Dimensional Culture Models of Breast Architecture, Function, and Neoplastic Transformation</article-title>. <source>Semin. Cancer Biol.</source> <volume>15</volume> (<issue>5</issue>), <fpage>342</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2005.05.001</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Bissell</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Of Extracellular Matrix, Scaffolds, and Signaling: Tissue Architecture Regulates Development, Homeostasis, and Cancer</article-title>. <source>Annu. Rev. Cel Dev. Biol.</source> <volume>22</volume>, <fpage>287</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.cellbio.22.010305.104315</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>A Possible Role of Vimentin on the Cell Surface for the Activation of Latent Transforming Growth Factor-&#x3b2;</article-title>. <source>FEBS Lett.</source> <volume>583</volume> (<issue>2</issue>), <fpage>308</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2008.12.051</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Manabe</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Macrophages in Inflammation, Repair and Regeneration</article-title>. <source>Int. Immunol.</source> <volume>30</volume> (<issue>11</issue>), <fpage>511</fpage>&#x2013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxy054</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Hendrickx</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Localisation of Glycoproteins and Glycosaminoglycans during Early Eye Development in the Macaque</article-title>. <source>J.&#x20;Anat.</source> <volume>186</volume> (<issue>Pt 1Pt 1</issue>), <fpage>31</fpage>&#x2013;<lpage>42</lpage>. </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richmond</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>J.&#x20;E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Immunology and Skin in Health and Disease</article-title>. <source>Cold Spring Harbor Perspect. Med.</source> <volume>4</volume> (<issue>12</issue>), <fpage>a015339</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a015339</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rilla</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pasonen-Sepp&#xe4;nen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rieppo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tammi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tammi</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The Hyaluronan Synthesis Inhibitor 4-methylumbelliferone Prevents Keratinocyte Activation and Epidermal Hyperproliferation Induced by Epidermal Growth Factor</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>123</volume> (<issue>4</issue>), <fpage>708</fpage>&#x2013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1111/j.0022-202X.2004.23409.x</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ripellino</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Bailo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>R. U.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Light and Electron Microscopic Studies on the Localization of Hyaluronic Acid in Developing Rat Cerebellum</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>106</volume> (<issue>3</issue>), <fpage>845</fpage>&#x2013;<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.106.3.845</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Sporn</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Assoian</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wakefield</surname>
<given-names>L. M.</given-names>
</name>
<etal/>
</person-group> (<year>1986</year>). <article-title>Transforming Growth Factor Type Beta: Rapid Induction of Fibrosis and Angiogenesis <italic>In Vivo</italic> and Stimulation of Collagen Formation <italic>In Vitro</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>83</volume> (<issue>12</issue>), <fpage>4167</fpage>&#x2013;<lpage>4171</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.83.12.4167</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roskelley</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Bissell</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Dynamic Reciprocity Revisited: a Continuous, Bidirectional Flow of Information between Cells and the Extracellular Matrix Regulates Mammary Epithelial Cell Function</article-title>. <source>Biochem. Cel Biol.</source> <volume>73</volume> (<issue>7-8</issue>), <fpage>391</fpage>&#x2013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1139/o95-046</pub-id> </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The Hyaluronan Synthesis Inhibitor 4-Methylumbelliferone Exhibits Antitumor Effects against Mesenchymal-like Canine Mammary Tumor Cells</article-title>. <source>Oncol. Lett.</source> <volume>5</volume> (<issue>3</issue>), <fpage>1068</fpage>&#x2013;<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2013.1124</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuel</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Hurta</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Spearman</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Turley</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>TGF-beta 1 Stimulation of Cell Locomotion Utilizes the Hyaluronan Receptor RHAMM and Hyaluronan</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>123</volume> (<issue>3</issue>), <fpage>749</fpage>&#x2013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.123.3.749</pub-id> </citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savani</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kinsella</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Wight</surname>
<given-names>T. N.</given-names>
</name>
<etal/>
</person-group> (<year>1995</year>). <article-title>Migration of Bovine Aortic Smooth Muscle Cells after Wounding Injury. The Role of Hyaluronan and RHAMM</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>95</volume> (<issue>3</issue>), <fpage>1158</fpage>&#x2013;<lpage>1168</lpage>. <pub-id pub-id-type="doi">10.1172/jci117764</pub-id> </citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultz</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Wysocki</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Interactions between Extracellular Matrix and Growth Factors in Wound Healing</article-title>. <source>Wound Repair Regen.</source> <volume>17</volume> (<issue>2</issue>), <fpage>153</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2009.00466.x</pub-id> </citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bochaton-Piallat</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Ropraz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Geinoz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borsi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zardi</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-&#x3b2;1</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>142</volume> (<issue>3</issue>), <fpage>873</fpage>&#x2013;<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.142.3.873</pub-id> </citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shigyo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tohda</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Extracellular Vimentin Is a Novel Axonal Growth Facilitator for Functional Recovery in Spinal Cord-Injured Mice</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>28293</fpage>. <pub-id pub-id-type="doi">10.1038/srep28293</pub-id> </citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shigyo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuboyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sawai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tada-Umezaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tohda</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Extracellular Vimentin Interacts with Insulin-like Growth Factor 1 Receptor to Promote Axonal Growth</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>12055</fpage>. <pub-id pub-id-type="doi">10.1038/srep12055</pub-id> </citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slevin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krupinski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gaffney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Matou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Delisser</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Hyaluronan-mediated Angiogenesis in Vascular Disease: Uncovering RHAMM and CD44 Receptor Signaling Pathways</article-title>. <source>Matrix Biol.</source> <volume>26</volume> (<issue>1</issue>), <fpage>58</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2006.08.261</pub-id> </citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spalton</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Posterior Capsular Opacification after Cataract Surgery</article-title>. <source>Eye</source> <volume>13</volume> (<issue>Pt 3b</issue>), <fpage>489</fpage>&#x2013;<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1038/eye.1999.127</pub-id> </citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>SundarRaj</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Gesiotto</surname>
<given-names>J.&#x20;P.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Expression of Vimentin by Rabbit Corneal Epithelial Cells during Wound Repair</article-title>. <source>Cell Tissue Res.</source> <volume>267</volume> (<issue>2</issue>), <fpage>347</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1007/bf00302973</pub-id> </citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Dally</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Steadman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moseley</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis</article-title>. <source>Biomolecules</source> <volume>11</volume> (<issue>8</issue>), <fpage>1095</fpage>. <pub-id pub-id-type="doi">10.3390/biom11081095</pub-id> </citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanihara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Inatani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Proteoglycans in the Eye</article-title>. <source>Cornea</source> <volume>21</volume> (<issue>7 Suppl. l</issue>), <fpage>S62</fpage>&#x2013;<lpage>S69</lpage>. <pub-id pub-id-type="doi">10.1097/01.ico.0000263121.45898.d2</pub-id> </citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teshigawara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuboyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shigyo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuya</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A Novel Compound, Denosomin, Ameliorates Spinal Cord Injury via Axonal Growth Associated with Astrocyte-Secreted Vimentin</article-title>. <source>Br. J.&#x20;Pharmacol.</source> <volume>168</volume> (<issue>4</issue>), <fpage>903</fpage>&#x2013;<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02211.x</pub-id> </citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theocharis</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Skandalis</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Noulas</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Papageorgakopoulou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Theocharis</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Karamanos</surname>
<given-names>N. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Hyaluronan and Chondroitin Sulfate Proteoglycans in the Supramolecular Organization of the Mammalian Vitreous Body</article-title>. <source>Connect. Tissue Res.</source> <volume>49</volume> (<issue>3</issue>), <fpage>124</fpage>&#x2013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1080/03008200802148496</pub-id> </citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tolg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Morningstar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Esguerra</surname>
<given-names>K. V.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>285</volume> (<issue>34</issue>), <fpage>26461</fpage>&#x2013;<lpage>26474</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.121491</pub-id> </citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tolg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Zalinska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>McCulloch</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Akentieva</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>A RHAMM Mimetic Peptide Blocks Hyaluronan Signaling and Reduces Inflammation and Fibrogenesis in Excisional Skin Wounds</article-title>. <source>Am. J.&#x20;Pathol.</source> <volume>181</volume> (<issue>4</issue>), <fpage>1250</fpage>&#x2013;<lpage>1270</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.06.036</pub-id> </citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tolg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cousteils</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Telmer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cell-Specific Expression of the Transcriptional Regulator RHAMM Provides a Timing Mechanism that Controls Appropriate Wound Re-epithelialization</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>295</volume> (<issue>16</issue>), <fpage>5427</fpage>&#x2013;<lpage>5448</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.010002</pub-id> </citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tolg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Messam</surname>
<given-names>B. J.-A.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Turley</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Hyaluronan Functions in Wound Repair that Are Captured to Fuel Breast Cancer Progression</article-title>. <source>Biomolecules</source> <volume>11</volume> (<issue>11</issue>), <fpage>1551</fpage>. <pub-id pub-id-type="doi">10.3390/biom11111551</pub-id> </citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uitto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>E. M. L.</given-names>
</name>
<name>
<surname>Ryhanen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Inhibition of Collagen Accumulation in Fibrotic Processes: Review of Pharmacologic Agents and New Approaches with Amino Acids and Their Analogues</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>79</volume> (<issue>Suppl. 1</issue>), <fpage>113s</fpage>&#x2013;<lpage>120s</lpage>. <pub-id pub-id-type="doi">10.1111/1523-1747.ep12545951</pub-id> </citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vigetti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rizzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Viola</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karousou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Genasetti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clerici</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>The Effects of 4-methylumbelliferone on Hyaluronan Synthesis, MMP2 Activity, Proliferation, and Motility of Human Aortic Smooth Muscle Cells</article-title>. <source>Glycobiology</source> <volume>19</volume> (<issue>5</issue>), <fpage>537</fpage>&#x2013;<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwp022</pub-id> </citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Immune Cells in Lens Injury Repair and Fibrosis</article-title>. <source>Exp. Eye Res.</source> <volume>209</volume>, <fpage>108664</fpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2021.108664</pub-id> </citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Activation of SRC Kinases Signals Induction of Posterior Capsule Opacification</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>48</volume> (<issue>5</issue>), <fpage>2214</fpage>&#x2013;<lpage>2223</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.06-1059</pub-id> </citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bleaken</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gerhart</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Unique Precursors for the Mesenchymal Cells Involved in Injury Response and Fibrosis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>107</volume> (<issue>31</issue>), <fpage>13730</fpage>&#x2013;<lpage>13735</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0910382107</pub-id> </citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Bleaken</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Establishment of a Clinically Relevant <italic>Ex Vivo</italic> Mock Cataract Surgery Model for Investigating Epithelial Wound Repair in a Native Microenvironment</article-title>. <source>JoVE</source> <volume>100</volume>, <fpage>e52886</fpage>. <pub-id pub-id-type="doi">10.3791/52886</pub-id> </citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Bleaken</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Romisher</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Alnwibit</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Menko</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>In Wound Repair Vimentin Mediates the Transition of Mesenchymal Leader Cells to a Myofibroblast Phenotype</article-title>. <source>MBoC</source> <volume>29</volume> (<issue>13</issue>), <fpage>1555</fpage>&#x2013;<lpage>1570</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E17-06-0364</pub-id> </citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walraven</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Therapeutic Approaches to Control Tissue Repair and Fibrosis: Extracellular Matrix as a Game Changer</article-title>. <source>Matrix Biol.</source> <volume>71-72</volume>, <fpage>205</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2018.02.020</pub-id> </citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Meran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steadman</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Modulation of TGF&#x3b2;1-dependent Myofibroblast Differentiation by Hyaluronan</article-title>. <source>Am. J.&#x20;Pathol.</source> <volume>175</volume> (<issue>1</issue>), <fpage>148</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2009.080837</pub-id> </citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilgus</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Growth Factor-Extracellular Matrix Interactions Regulate Wound Repair</article-title>. <source>Adv. Wound Care</source> <volume>1</volume> (<issue>6</issue>), <fpage>249</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2011.0344</pub-id> </citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wormstone</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Eldred</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Experimental Models for Posterior Capsule Opacification Research</article-title>. <source>Exp. Eye Res.</source> <volume>142</volume>, <fpage>2</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2015.04.021</pub-id> </citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wormstone</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. S. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Posterior Capsule Opacification</article-title>. <source>Exp. Eye Res.</source> <volume>88</volume> (<issue>2</issue>), <fpage>257</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2008.10.016</pub-id> </citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wormstone</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Wormstone</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A. J.&#x20;O.</given-names>
</name>
<name>
<surname>Eldred</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Posterior Capsule Opacification: What&#x27;s in the Bag?</article-title> <source>Prog. Retin. Eye Res.</source> <volume>82</volume>, <fpage>100905</fpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2020.100905</pub-id> </citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Sabino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Minkhorst</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yazdani</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Function-Blocking RHAMM Peptides Attenuate Fibrosis and Promote Antifibrotic Adipokines in a Bleomycin-Induced Murine Model of Systemic Sclerosis</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>141</volume> (<issue>6</issue>), <fpage>1482</fpage>&#x2013;<lpage>1492.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2019.11.032</pub-id> </citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Noureddin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Ramnath</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Hyaluronan Synthase 2-mediated Hyaluronan Production Mediates Notch1 Activation and Liver Fibrosis</article-title>. <source>Sci. Transl. Med.</source> <volume>11</volume> (<issue>496</issue>), <fpage>eaat9284</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aat9284</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>